Skip to main content
. 2021 Jun 29;12:653521. doi: 10.3389/fphar.2021.653521

FIGURE 2.

FIGURE 2

Global response rate for patients of CR (A), PR (B), ORR (C), DCR (D), 1-year OS rate (E), and 6-months PFS rate (F). The global response rate consists of CR, PR, ORR, and DCR. The global CR was 1.26% (95% CI, 0.35–2.54; I2, 19.10), PR was 7.65% (95% CI, 3.32–13.37; I2, 76.40), ORR was 9.85% (95% CI, 4.40–16.95; I2, 81.60), and DCR was 18.33% (95% CI, 12.1827.59; I2, 79.20) (A–D). 1-year overall survival rate and 6-months progression-free survival rate were 43.34% (95% CI, 35.70–51.15; I2, 68.70), and 17.24% (95% CI, 10.70–23.78; I2, 67.80) (EF).